Pluripotent stem cells, a potential source of β-cells for diabetes therapy

Current Opinion in Investigational Drugs

Volumn 11, Issue 4, 2010, Pages 417-425

  Hansson, Mattias ^a   Madsen, Ole D ^a  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

cell; Cell replacement therapy; Diabetes mellitus; Insulin; Pluripotent stem cell; T1DM

Indexed keywords

RAPAMYCIN;

DIABETES MELLITUS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNER CELL MASS; NONHUMAN; ONTOGENY; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-SECRETING CELLS; PLURIPOTENT STEM CELLS; PREGNANCY; STEM CELLS;

EID: 77950107335     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. IDF Diabetes Atlas Foreward. International Diabetes Federation, Brussels, Belgium (2009). www.diabetesatlas.org/content/ foreword
2. American Diabetes Association: Economic costs of diabetes in the US in 2007. Diabetes Care (2008) 31(3):596-615.
3. Sowers JR, Lester MA: Diabetes and cardiovascular disease. Diabetes Care (1999) 22(Suppl 3):C14-C20.
4. MacGillivray MH, Voorhess ML, Putnam TI, Li PK, Schaefer PA, Bruck E: Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus. Diabetes Care (1982) 5(Suppl 1):38-47.
5. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 353(25):2643-2653.
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med (1993) 329(14): 977-986.
7. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med (2000) 342(6):381-389.
8. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet (1998) 352(9131):837-853.
9. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ (Ed): Joslin's Diabetes Mellitus. Lippincott Williams & Wilkins, Philadelphia, PA, USA (2005).
10. Eizirik DL, Colli ML, Ortis F: The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol (2009) 5(4):219-226.
11. Rosenfeld L: Insulin: Discovery and controversy. Clin Chem (2002) 48(12):2270-2288.
12. Hirsch IB: Insulin analogues. N Engl J Med (2005) 352(2): 174-183.
13. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM: Five-year follow-up after clinical islet transplantation. Diabetes (2005) 54(7):2060-2069.
14. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E et al: International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 355(13): 1318-1330.
15. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD et al: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol (2008) 26(4):443-452.
16. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE: Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol (2006) 24(11):1392-1401.
17. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE: Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol (2005) 23(12):1534-1541.
18. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y: Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem (2008) 283(46):31601-31607.
19. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H: Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res (2009) 19(4):429-438.
20. Wiliams PW: Notes on diabetes treated with extract and by grafts of sheep's pancreas. Br Med J (1894) 2:1303-1304.
21. White SA, Shaw JA, Sutherland DE: Pancreas transplantation. Lancet (2009) 373(9677):1808-1817.
22. Ballinger WF, Lacy PE: Transplantation of intact pancreatic islets in rats. Surgery (1972) 72(2):175-186.
23. Sutherland DE, Matas AJ, Goetz FC, Najarian JS: Transplantation of dispersed pancreatic islet tissue in humans: Autografts and allografts. Diabetes (1980) 29(Suppl 1):31-44.
24. Najarian JS, Sutherland DE, Baumgartner D, Burke B, Rynasiewicz JJ, Matas AJ, Goetz FC: Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 192(4):526-542.
25. Largiader F, Kolb E, Binswanger U: A long-term functioning human pancreatic islet allotransplant. Transplantation (1980) 29(1):76-77.
26. The International Islet Transplant Registry: Newsletter #9. Third Medical Department, Center of Internal Medicine, University Hospital Giessen, Giessen, Germany (2001) 8(1):1-20. www.med. uni-giessen.de/itr/newsletter/no-9/news-9.pdf
27. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen. N Engl J Med (2000) 343(4): 230-238.
28. Berney T, Ferrari-Lacraz S, Buhler L, Oberholzer J, Marangon N, Philippe J, Villard J, Morel P: Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark. Am J Transplant (2009) 9(2):419-423.
29. Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G, Majumdar AS: Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells (2007) 25(8):1940-1953.
30. Phillips BW, Hentze H, Rust WL, Chen QP, Chipperfield H, Tan EK, Abraham S, Sadasivam A, Soong PL, Wang ST, Lim R et al: Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev (2007) 16(4): 561-578.
31. Tam PP, Loebel DA: Gene function in mouse embryogenesis: Get set for gastrulation. Nat Rev Genet (2007) 8(5):368-381.
32. Pictet RL, Clark WR, Williams RH, Rutter WJ: An ultrastructural analysis of the developing embryonic pancreas. Dev Biol (1972) 29(4):436-467.
33. Wessels NK, Cohen JH: Early pancreas organogenesis: Morphogenesis, tissue interactions, and mass effects. Dev Biol (1967) 15(3):237-270.
34. Jørgensen MC, Ahnfelt-Rønne J, Hald J, Madsen OD, Serup P, Hecksher-Sørensen J: An illustrated review of early pancreas development in the mouse. Endocr Rev (2007) 28(6):685-705.
35. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoterfactor 1 is required for pancreas development in mice. Nature (1994) 371(6498):606-609.
36. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development (1996) 122(3):983-995.
37. Ahlgren U, Jonsson J, Edlund H: The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development (1996) 122(5):1409-1416.
38. Gu G, Dubauskaite J, Melton DA: Direct evidence for the pancreatic lineage: Ngn3+ cells are islet progenitors and are distinct from duct progenitors. Development (2002) 129(10): 2447-2457.
39. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N, Hagenbuchle O, Wellauer PK: The bHLH protein Ptf1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev (1998) 12(23):3752-3763.
40. Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CV: The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet (2002) 32(1):128-134.
41. Hald J, Sprinkel AE, Ray M, Serup P, Wright C, Madsen OD: Generation and characterization of Ptf1a antiserum and localization of Ptf1a in relation to Nkx6.1 and Pdx1 during the earliest stages of mouse pancreas development. J Histochem Cytochem (2008) 56(6):587-595.
42. Gradwohl G, Dierich A, LeMeur M, Guillemot F: Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA (2000) 97(4): 1607-1611.
43. Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G, Gruss P: Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev (2003) 17(20): 2591-2603.
44. Collombat P, Hecksher-Sorensen J, Broccoli V, Krull J, Ponte I, Mundiger T, Smith J, Gruss P, Serup P, Mansouri A: The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the and β-cell lineages in the mouse endocrine pancreas. Development (2005) 132(13):2969-2980.
45. Collombat P, Xu X, Ravassard P, Sosa-Pineda B, Dussaud S, Billestrup N, Madsen OD, Serup P, Heimberg H, Mansouri A: The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into and subsequently cells. Cell (2009) 138(3):449-462.
46. Zhang C, Moriguchi T, Kajihara M, Esaki R, Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, Kudo T et al: MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol (2005) 25(12):4969-4976.
47. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA: In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature (2008) 455(7213):627-632.
48. Gittes GK: Developmental biology of the pancreas: A comprehensive review. Dev Biol (2009) 326(1):4-35.
49. Weissman IL, Anderson DJ, Gage F: Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol (2001) 17:387-403.
50. Smith AG: Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol (2001) 17:435-462.
51. Nir T, Melton DA, Dor Y: Recovery from diabetes in mice by cell regeneration. J Clin Invest (2007) 117(9):2553-2561.
52. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 429(6987):41-46.
53. Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, Morita R, Sharma A, Bonner-Weir S: Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci USA (2008) 105(50):19915-19919.
54. Minami K, Okuno M, Miyawaki K, Okumachi A, Ishizaki K, Oyama K, Kawaguchi M, Ishizuka N, Iwanaga T, Seino S: Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc Natl Acad Sci USA (2005) 102(42):15116-15121.
55. Desai BM, Oliver-Krasinski J, De Leon DD, Farzad C, Hong N, Leach SD, Stoffers DA: Preexisting pancreatic acinar cells contribute to acinar cell, but not islet β cell, regeneration. J Clin Invest (2007) 117(4):971-977.
56. Xu X, D'Hoker J, Stangé G, Bonné S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D, Bouwens L et al: cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell (2008) 132(2):197-207.
57. Seaberg RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, Korbutt G, van der Kooy D: Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol (2004) 22(9):1115-1124.
58. Chambers I, Tomlinson SR: The transcriptional foundation of pluripotency. Development (2009) 136(14):2311-2322.
59. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 126(4):663-676.
60. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 131(5):861-872.
61. Meissner A, Wernig M, Jaenisch R: Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 25(10):1177-1181.
62. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II et al: Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 318(5858):1917-1920.
63. Borowiak M, Maehr R, Chen S, Chen AE, Tang W, Fox JL, Schreiber SL, Melton DA: Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell (2009) 4(4):348-358.
64. Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, Davidow L, Lam K, Peng LF, Schreiber SL, Rubin LL, Melton D: A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol (2009) 5(4):258-265.
65. Zhu S, Wurdak H, Wang J, Lyssiotis CA, Peters EC, Cho CY, Wu X, Schultz PG: A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell (2009) 4(5):416-426.
66. Zhou J, Su P, Wang L, Chen J, Zimmermann M, Genbacev O, Afonja O, Horne MC, Tanaka T, Duan E, Fisher SJ et al: mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci USA (2009) 106(19):7840-7845.
67. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A: Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 6(5):568-572.
68. Yang L, Li S, Hatch H, Ahrens K, Cornelius JG, Petersen BE, Peck AB: In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA (2002) 99(12):8078-8083.
69. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, Chan L: NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med (2003) 9(5):596-603.
70. Cao LZ, Tang DQ, Horb ME, Li SW, Yang LJ: High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes (2004) 53(12):3168-3178.
71. Kim S, Shin JS, Kim HJ, Fisher RC, Lee MJ, Kim CW: Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration. Lab Invest (2007) 87(7): 702-712.
72. Suzuki A, Nakauchi H, Taniguchi H: Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA (2003) 100(9):5034-5039.
73. Yoshida S, Kajimoto Y, Yasuda T, Watada H, Fujitani Y, Kosaka H, Gotow T, Miyatsuka T, Umayahara Y, Yamasaki Y, Hori M: Pdx-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes (2002) 51(8):2505-2513.
74. Kojima H, Nakamura T, Fujita Y, Kishi A, Fujimiya M, Yamada S, Kudo M, Nishio Y, Maegawa H, Haneda M, Yasuda H et al: Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes (2002) 51(5):1398-1408.
75. Okumura K, Nakamura K, Hisatomi Y, Nagano K, Tanaka Y, Terada K, Sugiyama T, Umeyama K, Matsumoto K, Yamamoto T, Endo F: Salivary gland progenitor cells induced by duct ligation differentiate into hepatic and pancreatic lineages. Hepatology (2003) 38(1):104-113.
76. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, Müller B, Zulewski H: Human adipose tissuederived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun (2006) 341(4):1135-1140.
77. Ianus A, Holz GG, Theise ND, Hussain MA: In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest (2003) 111(6):843-850.
78. Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H, Migita M, Shimada T, Kawamori R, Watada H: Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic β cell,. Diabetologia (2003) 46(10):1366-1374.
79. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M: Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 21(7):763-770.
80. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA: Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury. Diabetes (2004) 53(1):91-98.
81. Estrada EJ, Valacchi F, Nicora E, Brieva S, Esteve C, Echevarria L, Froud T, Bernetti K, Cayetano SM, Velazquez O, Alejandro R et al: Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant (2008) 17(12):1295-1304.
82. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA: Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol (2008) 36(6):710-715.
83. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ et al: C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA (2009) 301(15):1573-1579.
84. Beck J, Angus R, Madsen B, Britt D, Vernon B, Nguyen KT: Islet encapsulation: Strategies to enhance islet cell functions. Tissue Eng (2007) 13(3):589-599.
85. Elster EA, Hale DA, Mannon RB, Cendales LC, Swanson SJ, Kirk AD: The road to tolerance: Renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transpl Immunol (2004) 13(2):87-99.
86. Cosimi AB, Sachs DH: Mixed chimerism and transplantation tolerance. Transplantation (2004) 77(6):943-946.
87. Bonde S, Chan KM, Zavazava N: ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 3(9):e3212.
88. Colman A, Dreesen O: Pluripotent stem cells and disease modeling. Cell Stem Cell (2009) 5(3):244-247.
89. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA: Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA (2009) 106(37):15768-15773.